SCHEMBL27207267

SCHEMBL27207267

CNC(=O)c1cccc(C(=O)c2ccccc2C)c1N1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.42
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
MT-CO2 P00403 1/20 0.40
HTR1A P08908 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
HTR3A P46098 2/20 0.40
HTR7 P34969 2/20 0.39
HPGD P15428 1/20 0.39
MAPK14 Q16539 2/20 0.39
PLK1 P53350 1/20 0.38
ALDH1A1 P00352 4/20 0.38
NPC1 O15118 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27207483 0.86 CYP3A4 (0.46) ADRB1HTR1ACYP1A2CYP3A4CYP2D6
SCHEMBL27207499 0.85 ADRB1 (0.44) ADRB1HTR1ACYP1A2CYP3A4CYP2D6
SCHEMBL27207290 0.83 CHRM3 (0.47) MAPK8MAPK9MAPK10GAASMN1; SMN2
SCHEMBL27202055 0.79 HTR6 (0.50) ADRB1MAPK8MAPK9MAPK10HTR3A
SCHEMBL4062286 0.76 ADRB1 (0.44) ADRB1MT-CO2HTR1ACYP1A2CYP3A4
SCHEMBL1742847 0.76 ADRB1 (0.51) ADRB1MAPK8MAPK9MAPK10HTR1A
SCHEMBL6890118 0.73 HTR2C (0.40) MAPK8MAPK9MAPK10MT-CO2HTR1A
SCHEMBL5745223 0.73 ADRB1 (0.49) ADRB1HTR1ACYP1A2CYP3A4CYP2D6
SCHEMBL5745278 0.72 ALDH1A1 (0.53) ADRB1HTR1ACYP1A2CYP3A4CYP2D6
SCHEMBL3951662 0.72 ADRB1 (0.47) ADRB1MT-CO2HTR1ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP MGMT, MCL1, FANCF ADRB1 4492/4885MAPK8 2927/4885MAPK9 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.